series-c-plus
Stage
4
Investors
About
Nimbus Therapeutics is a biotechnology company that develops small-molecule therapeutics using computational chemistry and structure-based drug discovery, collaborating with biopharma to advance drug candidates.
Explore Nimbus Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.